Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients.

Due to this close resemblance to the human tumor, TumorGrafts are highly predictive of treatment outcomes in patients.

[5] [citation needed] TumorGrafts are also being used as a pre-clinical research tool to improve clinical drug development.

For patients whose tumors have also undergone molecular testing, such as next-generation sequencing, the selection of potential drugs is further guided by any and all applicable results.

In the event the cancer progresses or recurs, Champions also banks, or stores, each successful TumorGraft for potential future patient use.